Vanguard Group’s Stericycle Inc SRCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-8,928,914
Closed -$545M 4355
2024
Q3
$545M Buy
8,928,914
+2,131
+0% +$126K 0.01% 988
2024
Q2
$519M Sell
8,926,783
-39,323
-0.4% -$2.02M 0.01% 975
2024
Q1
$473M Sell
8,966,106
-3,012
-0% -$152K 0.01% 1028
2023
Q4
$445M Buy
8,969,118
+52,576
+0.6% +$2.36M 0.01% 1034
2023
Q3
$399M Sell
8,916,542
-32,579
-0.4% -$1.46M 0.01% 1022
2023
Q2
$416M Sell
8,949,121
-24,002
-0.3% -$1.05M 0.01% 1034
2023
Q1
$391M Buy
8,973,123
+127,922
+1% +$6.33M 0.01% 1047
2022
Q4
$441M Buy
8,845,201
+163,313
+2% +$7.77M 0.01% 952
2022
Q3
$366M Buy
8,681,888
+139,456
+2% +$6.71M 0.01% 1022
2022
Q2
$375M Buy
8,542,432
+135,943
+2% +$6.74M 0.01% 1038
2022
Q1
$495M Buy
8,406,489
+47,737
+0.6% +$2.76M 0.01% 973
2021
Q4
$499M Buy
8,358,752
+31,925
+0.4% +$2M 0.01% 999
2021
Q3
$566M Sell
8,326,827
-21,389
-0.3% -$1.48M 0.01% 910
2021
Q2
$597M Buy
8,348,216
+107,138
+1% +$7.88M 0.01% 884
2021
Q1
$556M Buy
8,241,078
+181,975
+2% +$12.4M 0.02% 890
2020
Q4
$559M Buy
8,059,103
+146,752
+2% +$10M 0.02% 826
2020
Q3
$499M Sell
7,912,351
-428,459
-5% -$26.3M 0.02% 781
2020
Q2
$467M Sell
8,340,810
-214,831
-3% -$11.2M 0.02% 793
2020
Q1
$416M Buy
8,555,641
+243,251
+3% +$14.3M 0.02% 740
2019
Q4
$530M Buy
8,312,390
+52,051
+0.6% +$3.08M 0.02% 791
2019
Q3
$421M Buy
8,260,339
+412,457
+5% +$19.2M 0.02% 881
2019
Q2
$375M Sell
7,847,882
-365,876
-4% -$18.6M 0.01% 957
2019
Q1
$447M Buy
8,213,758
+41,488
+0.5% +$1.88M 0.02% 843
2018
Q4
$300M Sell
8,172,270
-843,718
-9% -$39.6M 0.01% 984
2018
Q3
$529M Buy
9,015,988
+228,533
+3% +$14.6M 0.02% 770
2018
Q2
$574M Buy
8,787,455
+148,935
+2% +$9.27M 0.02% 701
2018
Q1
$506M Buy
8,638,520
+97,732
+1% +$6.62M 0.02% 756
2017
Q4
$581M Buy
8,540,788
+101,723
+1% +$6.91M 0.03% 691
2017
Q3
$604M Buy
8,439,065
+104,528
+1% +$7.69M 0.03% 637
2017
Q2
$636M Buy
8,334,537
+240,327
+3% +$19.7M 0.03% 598
2017
Q1
$671M Buy
8,094,210
+251,061
+3% +$20.2M 0.03% 569
2016
Q4
$604M Buy
7,843,149
+205,044
+3% +$15.5M 0.03% 587
2016
Q3
$612M Buy
7,638,105
+166,611
+2% +$15.1M 0.04% 559
2016
Q2
$778M Buy
7,471,494
+135,168
+2% +$14.5M 0.05% 457
2016
Q1
$926M Buy
7,336,326
+183,793
+3% +$21.4M 0.06% 369
2015
Q4
$863M Buy
7,152,533
+179,540
+3% +$22.9M 0.06% 373
2015
Q3
$971M Buy
6,972,993
+136,248
+2% +$19M 0.07% 304
2015
Q2
$916M Buy
6,836,745
+151,744
+2% +$20.8M 0.06% 357
2015
Q1
$939M Buy
6,685,001
+319,940
+5% +$43.2M 0.06% 345
2014
Q4
$834M Buy
6,365,061
+247,634
+4% +$31.2M 0.06% 360
2014
Q3
$713M Buy
6,117,427
+134,650
+2% +$15.9M 0.06% 388
2014
Q2
$708M Buy
5,982,777
+99,038
+2% +$11.3M 0.06% 387
2014
Q1
$669M Buy
5,883,739
+146,757
+3% +$17M 0.06% 382
2013
Q4
$666M Buy
5,736,982
+93,372
+2% +$10.9M 0.06% 367
2013
Q3
$651M Buy
5,643,610
+93,495
+2% +$10.8M 0.06% 343
2013
Q2
$613M Buy
+5,550,115
New +$603M 0.06% 340

Other funds holding SRCL

Vanguard Group's SRCL Position: Q4 2024 in Review

Vanguard Group sold out of Stericycle Inc (SRCL) in Q4 2024, closing a stake of 8,928,914 shares — an estimated $545M sold.

Vanguard Group first reported a position in SRCL in Q2 2013 and held it in 46 quarters. The position peaked at $971M in Q3 2015. 4 funds tracked by Wall St. Rank hold SRCL as of Q4 2024.

  • Vanguard Group reported no remaining Stericycle Inc position as of Q4 2024 after selling out during the quarter.
  • Vanguard Group sold 8,928,914 Stericycle Inc shares in Q4 2024, an estimated $545M.
  • Vanguard Group first reported a position in Stericycle Inc in Q2 2013 and held it in 46 quarters.
  • Vanguard Group's Stericycle Inc position peaked at $971M in Q3 2015.
  • 4 funds tracked by Wall St. Rank held Stericycle Inc as of Q4 2024.

Based on Vanguard Group's 13F filing for Q4 2024, filed 11 Feb 2025.